以结构为导向的诺林衍生物的开发,以准素螺旋蛋白为目标
Rohini S Kavalapure1, Shankar G Alegaon1, Shankar Gharge1
1Department of Pharmaceutical Chemistry, KLE College of Pharmacy, Belagavi, KLE Academy of Higher education and Research, Belagavi 590 010, Karnataka, India.
Bioorganic & medicinal chemistry letters
|May 17, 2025
概括
新的化衍生物通过抑制细胞分裂至关重要的Eg5蛋白来显示出作为癌症治疗的前景. 化合物6d和6e对乳腺癌细胞表现出显著的抗癌活性.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 基因素Eg5蛋白对于线粒分裂至关重要,也是癌症化疗的验证标.
- 开发新的Eg5抑制剂对于推进癌症治疗策略至关重要.
研究的目的:
- 设计,合成和评估新型的2- ((((7-chloroquinolin-4-yl) 氨基) 化衍生物作为潜在的Eg5抑制剂.
- 评估这些化合物对人类乳腺癌细胞 (MCF-7) 的抗增殖活性.
主要方法:
- 化衍生物的合成和表征.
- 在体外酶抑制试验测试以确定与Eg5.5对比的IC50值.
- 基于细胞的测试,以评估对MCF-7细胞的抗增殖作用.
- 计算研究包括药模拟,分子对接,分子动力学 (MD) 模拟和MM/GBSA分析.
主要成果:
- 化合物6d和6e显示出强大的Eg5抑制,IC50值分别为1.519 ± 0.4415μM和0.2848 ± 0.070μM.
- 这些化合物对MCF-7乳腺癌细胞表现出显著的抗增殖活性.
- 计算分析证实了Eg5活性部位内的6d和6e化合物的有利结合相互作用.
- 发现这些化合物能调节关键的与癌症相关的信号通路,包括PI3K-Akt和MAPK.
结论:
- 设计的2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 氨基) 化衍生物,特别是化合物6d和6e,是有效的Eg5抑制剂.
- 化合物6d和6e显示出作为乳腺癌治疗的抗癌剂的显著潜力.
- 需要进一步的体内研究来验证这些有前途的化合物的治疗疗效.
相关概念视频
The Movement of Organelles and Vesicles
4.3K
In eukaryotic cells, cytoskeletal filaments such as actin, microtubules, and intermediate filaments form a mesh-like cytoskeletal network. These filaments serve as tracks for transporting cellular cargo. Specialized motor proteins use the chemical energy stored in adenosine triphosphate (ATP) for this transport. During interphase, microtubules are polarized, with the plus-end towards the cell periphery and the minus-end towards the cell center. Two microtubule-associated motor proteins,...
4.3K
Destabilization of Microtubules
2.5K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.5K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Anaphase A and B
3.9K
Microtubules form through the end-to-end polymerization of tubulin heterodimers. Kinetochore microtubules originate from the spindle poles, and their plus-ends connect with the kinetochores on sister-chromatids. Ndc80 protein complexes, present on the kinetochore, form low-affinity links with the plus end of these kinetochore microtubules.
Plus-end depolymerization releases tubulin heterodimers from the terminal region of the microtubule. As tubulin subunits are lost, the Ndc80 complexes detach...
Plus-end depolymerization releases tubulin heterodimers from the terminal region of the microtubule. As tubulin subunits are lost, the Ndc80 complexes detach...
3.9K
Studying the Cytoskeleton
5.8K
The cytoskeletal architecture can be studied using different microscopic and biochemical techniques. Electron microscopy was instrumental in discovering the cytoskeletal architecture around the 1960s, which allowed obtaining structural information at a high-resolution level. However, the sample preparation procedure often limits this ability in biological samples. Several protocols have been developed over the years to optimize sample preparation. In one of the protocols known as rotary...
5.8K
Spindle Assembly
3.5K
Spindle assembly occurs through three, often coexisting, pathways – the centrosome-mediated pathway, the chromatin-mediated pathway, and the microtubule-mediated pathway – collectively contributing to form a robust spindle apparatus.
In most cells, centrosomes are the primary microtubule nucleation centers. In the centrosome-mediated pathway, the G2-prophase transition triggers centrosome maturation and increased microtubule nucleation. Progressive nucleation results in a...
In most cells, centrosomes are the primary microtubule nucleation centers. In the centrosome-mediated pathway, the G2-prophase transition triggers centrosome maturation and increased microtubule nucleation. Progressive nucleation results in a...
3.5K


